Glucotrack (GCTK) Other financing activities (2013 - 2024)

Glucotrack's (GCTK) quarterly Other financing activities came in at -$400000.0 in Q4 2024, down 80708.08% on a QoQ basis from -$495.0 in Q4 2019.

Glucotrack (GCTK) Other financing activities (2013 - 2024) Analysis & Trends

Glucotrack (GCTK) has 4 years of Other financing activities data on file, last reported at -$400000.0 in Q4 2024.

Quarterly Other financing activities changed N/A year-over-year to -$400000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$400495.0 (changed N/A YoY) and the FY2025 annual result came in at $3.5 million, up 3444.0% from the prior year.
Other financing activities eased to -$400000.0 in Q4 2024, from -$495.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of -$400000.0 in Q4 2024 to a low of -$400000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn
10	Glucotrack	1.68 Mn	553,542.53	-

Download Data